Headspace vs Hims & Hers
Side-by-side comparison of AI visibility scores, market position, and capabilities
Headspace is a mindfulness and mental health app offering guided meditation, sleep content, and enterprise employee wellbeing programs to over 70 million users.
About
Headspace is a mental wellness company founded in 2010 by Andy Puddicombe and Rich Pierson that has grown into one of the most widely used mindfulness and meditation apps globally. The platform offers guided meditation sessions, sleep content, stress reduction exercises, and mental fitness programs for both individual consumers and enterprise employees through its Headspace for Work product. Headspace merged with Ginger, a mental health coaching and therapy platform, in 2021 to form Headspace Health, expanding from mindfulness content into clinical mental health services. The combined platform provides a continuum from self-guided wellness content through human-delivered coaching and therapy, serving both consumers and employers who want comprehensive mental health benefits. Headspace for Work serves over 4,000 employer customers providing evidence-backed mental wellness programs to millions of employees globally. The company has published research demonstrating measurable improvements in stress, burnout, and resilience from Headspace use. Following the merger, Headspace has integrated its consumer brand recognition with Ginger's clinical platform to serve the full spectrum of mental health needs.
Consumer telehealth platform with Q3 2025 revenue of $599M (+49% YoY); 2.47M subscribers; 2025 guidance $2.3-2.4B; acquiring ZAVA for European expansion; GLP-1 weight loss, hair, and sexual health treatments shipped directly to subscribers.
About
Hims & Hers is a consumer telehealth and pharmacy platform founded in 2017 in San Francisco by Andrew Dudum, built on the mission of making high-quality healthcare affordable and stigma-free for conditions that people historically avoided treating due to embarrassment, cost, or access barriers. The platform's core technology combines a direct-to-consumer digital health interface with an integrated pharmacy network, enabling patients to complete asynchronous or synchronous consultations with licensed clinicians and receive prescription treatments — including compounded medications — delivered directly to their homes.\n\nHims & Hers serves patients across sexual health, hair loss, mental health, dermatology, and weight management. The company's expansion into GLP-1 compounded weight loss medications has been a significant growth catalyst, capitalizing on surging consumer demand for semaglutide and tirzepatide alternatives during periods of branded drug shortages. With 2.47 million subscribers and a subscription-centric business model, the platform generates predictable recurring revenue from patients on ongoing treatment protocols. The company's 2025 acquisition of ZAVA expands its addressable market into European telehealth markets.\n\nHims & Hers reported Q3 revenue of $599 million, a 49% year-over-year increase, and issued full-year 2025 guidance of $2.3 to $2.4 billion — a scale that makes it one of the largest consumer telehealth companies in the world. The company's ability to compound subscriber growth with expanding treatment categories and international expansion through ZAVA provides multiple vectors for continued revenue acceleration. As healthcare consumerization intensifies and patients increasingly manage chronic conditions through digital-first platforms, Hims & Hers' brand recognition, integrated pharmacy infrastructure, and subscription model give it a durable position in consumer health.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Headspace vs
Hims & Hers vs
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.